Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, David Kudrow, Eric Pearlman et al.|Cephalalgia|2019Cited by 99
Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in MigraineDavid Hewitt, Tony W. Ho, Eleanor Schaefer et al.|Headache The Journal of Head and Face Pain|2011Cited by 36
Effect of Fremanezumab on the Total Burden of Migraine in Patients with Episodic or Chronic Migraine: Findings from 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies (2439)Christina Sun‐Edelstein, Jan Lewis Brandes, Joshua M. Cohen et al.|Neurology|2021Cited by 0